摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

四氢-2H-吡喃-3-酮 | 23462-75-1

中文名称
四氢-2H-吡喃-3-酮
中文别名
3-酮吡喃;2H-吡喃-3(4H)-酮,二氢;四氢吡喃-3-酮;二氢-吡喃-3-酮
英文名称
5,6-dihydro-2H-pyran-3(4H)-one
英文别名
dihydro-2H-pyran-3(4H)-one;tetrahydropyran-3-one;oxan-3-one;5,6-Dihydro-2H-pyran-3(4H)-on;Tetrahydropyran-3-on;tetrahydro-2H-pyran-3-one;Tetrahydro-3-pyranone;Tetrahydro-3-pyranon;3-oxacyclohexanone
四氢-2H-吡喃-3-酮化学式
CAS
23462-75-1
化学式
C5H8O2
mdl
MFCD00182426
分子量
100.117
InChiKey
URUUZIAJVSGYRC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    55 °C(Press: 12 Torr)
  • 密度:
    1.0856 g/cm3
  • 保留指数:
    877.3

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2932999099
  • 危险性防范说明:
    P261,P301+P312,P302+P352,P304+P340,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    -20°C,保存于惰性气体中

SDS

SDS:72d2a3493e688e69e149b70ba5c7915c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Dihydro-2h-pyran-3(4h)-one
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Dihydro-2h-pyran-3(4h)-one
CAS number: 23462-75-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H8O2
Molecular weight: 100.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

四氢-2H-吡喃-3-酮是一种有机合成中间体和医药中间体,广泛应用于实验室研发以及医药和生物化工的生产过程中。

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    —— 4-methyldihydro-2H-pyran-3(4H)-one 60467-47-2 C6H10O2 114.144

反应信息

  • 作为反应物:
    描述:
    四氢-2H-吡喃-3-酮potassium tert-butylate 、 sodium hydroxide 作用下, 以 乙二醇二甲醚乙醇叔丁醇 为溶剂, 反应 6.0h, 生成 tetrahydro-2H-pyran-3-carboxylic acid
    参考文献:
    名称:
    N-Methyl-N-phenyl-5-oxa-1-azaspiro[2.5]oct-1-en-2-amine — Synthesis and Reactions of a Synthon for an Unknown α-Amino Acid
    摘要:
    The synthesis of the heterospirocyclic amino azirine N-methyl-N-phenyl-5-oxa-1-azaspiro[2.5]oct-1-en-2-amine (6a) was achieved from 3,4-dihydro-2H-pyrane (7) via N-methyl-N-phenyltetrahydropyran-3-thiocarboxamide (11). The reactions of 6a with thiobenzoic acid and Z-Phe-OH, respectively, leading to the corresponding 3-benzoylaminotetrahydropyran-3-thiocarboxamide (13) and the diastereoisomeric dipeptide amides (14), respectively, demonstrate that 6a is a valuable synthon for the hitherto unknown 3-aminotetrahydropyrane-3-carboxylic acid. The structure of 13 was established by X-Ray crystallography.
    DOI:
    10.3987/com-10-s(e)73
  • 作为产物:
    描述:
    alpha-酮戊二酸 在 lithium aluminium tetrahydride 、 硫酸 、 sodium hydride 、 三氟乙酸 作用下, 以 四氢呋喃甲醇二氯甲烷 、 mineral oil 为溶剂, 反应 39.0h, 生成 四氢-2H-吡喃-3-酮
    参考文献:
    名称:
    二氢-2H-吡喃-3(4H)-one的合成
    摘要:
    报道了合成 dihydro-2H-pyran-3(4H)-one 的实用合成程序。该方法从容易获得的β-酮戊二酸开始,并允许分四步以31%的总产率制备标题化合物。
    DOI:
    10.3998/ark.5550190.0013.820
点击查看最新优质反应信息

文献信息

  • [EN] THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE<br/>[FR] DÉRIVÉS DE THIOPHÈNE POUR LE TRAITEMENT DE TROUBLES PROVOQUÉS PAR IGE
    申请人:UCB BIOPHARMA SRL
    公开号:WO2019243550A1
    公开(公告)日:2019-12-26
    Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.
    提供了公式(I)的噻吩衍生物及其药用可接受的盐。这些化合物对于治疗或预防由IgE引起的疾病具有用途,如过敏、1型超敏反应或家族性鼻窦炎。
  • IDO INHIBITORS
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US20160289171A1
    公开(公告)日:2016-10-06
    There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    已披露的化合物可调节或抑制吲哌酮胺2,3-二氧化酶(IDO)的酶活性,含有该化合物的药物组合物以及利用本发明的化合物治疗增殖性疾病,如癌症、病毒感染和/或炎症性疾病的方法。
  • Synthese und pharmakologische Prüfung ZNS-wirksamer Phenyl-tetrahydropyrane und -thiopyrane: Oxa- und Thia-phencyclidine
    作者:Fritz Eiden、Michael Schmidt、Helga Buchborn
    DOI:10.1002/ardp.19873200413
    日期:——
    Aus den Pyranonen 2 und 14 sowie den Thiopyranonen 3 und 15 wurden Phencyclidin‐oxa‐ und ‐thiaanaloge dargestellt. An Mäusen zeigten die Pyranderivate ein günstigeres Verhältnis von Analgesie und Erregung als Phencyclidin. Während die analgetischen Eigenschaften der Enantiomere (+)‐20b und (−)‐20b gleich waren, ließ sich eine erregende Wirkung bei (+)‐20b nicht mehr feststellen. Die Thiopyranderivate
    由吡喃酮 2 和 14 以及吡喃酮 3 和 15 制备苯环利定氧杂和硫杂类似物。在小鼠中,吡喃衍生物显示出比苯环利定更有利的镇痛和唤醒比率。虽然对映异构体 (+) - 20b 和 (-) - 20b 的镇痛特性相同,但 (+) - 20b 不再能确定令人兴奋的效果。噻喃衍生物无效。
  • Regiochemical control of the ring opening of 1,2-epoxides by means of chelating processes. Part 15: Regioselectivity of the opening reactions with MeOH of remote O-substituted regio- and diastereoisomeric pyranosidic epoxides under condensed- and gas-phase operating conditions
    作者:Paolo Crotti、Gabriele Renzi、Lucilla Favero、Graziella Roselli、Valeria Di Bussolo、Micaela Caselli
    DOI:10.1016/s0040-4020(03)00078-4
    日期:2003.2
    The regiochemical behavior of pairs of regio- and diastereoisomeric epoxides derived from the 3,4,5,6-tetrahydro-2H-pyrane system, bearing an acetal group as the remote functionality, was determined in the acid methanolysis in the condensed phase (cd-phase) and in the reaction with MeOH in the gas-phase using a gaseous acid (D3+), as the promoting agent. With only one exception, the results obtained
    在缩合相的酸性甲醇分解中,确定了由3,4,5,6-四氢-2 H-吡喃体系衍生的成对的对-对映体和非对映异构体环氧化物的对区域化学行为(以缩醛为远程官能团)( cd-相)和在气相中与MeOH的反应中,使用气态酸(D 3 +)作为促进剂。仅有一个例外,在这些环氧化物的打开过程中获得的结果表明,D +介导的螯合双齿物种在气相中的侵入能够改变在cd相甲醇解中发现的区域化学结果。
  • 吡咯并吡唑类衍生物、其制备方法及其在医药上的应用
    申请人:上海美迪西生物医药股份有限公司
    公开号:CN110194773A
    公开(公告)日:2019-09-03
    本发明涉及吡咯并吡唑类衍生物、其制备方法及其在医药上的应用。具体的说,本发明涉及一类通式(I)所示的新的吡咯并吡唑类衍生物、其制备方法以及其本身或含有此类衍生物的药物组合物作为治疗剂,特别是作为胃酸分泌抑制剂和钾离子竞争性酸阻滞剂(P‑CABs)在生物医药中的用途。其中通式(I)中的各取代基(R1、R2、R3)和基团(X、Y、Z)与说明书中的定义相同。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(3S,4R)-3-氟四氢-2H-吡喃-4-胺 鲁比前列素中间体 顺-4-(四氢吡喃-2-氧)-2-丁烯-1-醇 顺-3-Boc-氨基-四氢吡喃-4-羧酸 锡烷,三丁基[3-[(四氢-2H-吡喃-2-基)氧代]-1-炔丙基]- 蒜味伞醇B 蒜味伞醇A 茉莉吡喃 苄基2,3-二-O-乙酰基-4-脱氧-4-C-硝基亚甲基-β-D-阿拉伯吡喃果糖苷 膜质菊内酯 红没药醇氧化物A 科立内酯 甲磺酸酯-四聚乙二醇-四氢吡喃醚 甲基[(噁烷-3-基)甲基]胺 甲基6-氧杂双环[3.1.0]己烷-2-羧酸酯 甲基4-脱氧吡喃己糖苷 甲基2,4,6-三脱氧-2,4-二-C-甲基吡喃葡己糖苷 甲基1,2-环戊烯环氧物 甲基-[2-吡咯烷-1-基-1-(四氢-吡喃-4-基)-乙基]-胺 甲基-(四氢吡喃-4-甲基)胺 甲基-(四氢吡喃-2-甲基)胺盐酸盐 甲基-(四氢吡喃-2-甲基)胺 甲基-(四氢-吡喃-3-基-胺 甲基-(四氢-吡喃-3-基)-胺盐酸盐 甲基-(4-吡咯烷-1-甲基四氢吡喃-4-基)-胺 甲基(5R)-3,4-二脱氧-4-氟-5-甲基-alpha-D-赤式-吡喃戊糖苷 环氧乙烷-2-醇乙酸酯 环己酮,6-[(丁基硫代)亚甲基]-2,2-二甲基-3-[(四氢-2H-吡喃-2-基)氧代]-,(3S)- 环丙基-(四氢-吡喃-4-基)-胺 玫瑰醚 独一味素B 溴-六聚乙二醇-四氢吡喃醚 氯菊素 氯丹环氧化物 氨甲酸,[[(四氢-2H-吡喃-2-基)氧代]甲基]-,乙基酯 氧化氯丹 正-(四氢-4-苯基-2h-吡喃-4-基)乙酰胺 次甲霉素 A 桉叶油醇 抗-11-氧杂三环[4.3.1.12,5]十一碳-3-烯-10-酮 戊二酸二甲酯 恩洛铂 异丙基-(四氢吡喃-4-基)胺 四氢吡喃醚-二聚乙二醇 四氢吡喃酮 四氢吡喃-4-醇 四氢吡喃-4-肼二盐酸盐 四氢吡喃-4-羧酸甲酯 四氢吡喃-4-羧酸噻吩酯